Under the 2019 amendment, contemporary medicine formulated with cannabis, hemp extract, or other cannabinoids expected regulatory evaluation and licensing within the Thai FDA underneath the Drug Act with on the list of prerequisite circumstances remaining which the cannabis has to be developed i